Indiana Statutes
§ 16-42-23-5 — Written informed request form
Indiana·Title 16 HEALTH·Art. 42 REGULATION OF FOOD, DRUGS, AND·Ch. 23 Drugs: Use of Amygdalin (Laetrile)
(a)The written informed request must be on
a form prepared by and obtained from the medical licensing board of
Indiana and must be in substance as follows:
My physician has explained the following to me:
(1)That the manufacture and distribution of amygdalin (laetrile)
has been banned by the Federal Food and Drug Administration.
(2)That neither the American Cancer Society, the American
Medical Association, nor the Indiana State Medical Association
recommend use of amygdalin (laetrile) in the treatment of a
malignancy, a disease, an illness, or a physical condition.
(3)That there are alternative recognized treatments for the
malignancy, disease, illness, or physical condition from which I
suffer that my physician has offered to provide for me, including
the following:
(Here describe)
___
Free access — add to your briefcase to read the full text and ask questions with AI
Indiana § 16-42-23-5 (Written informed request form) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.
Legislative History
As added by P.L.2-1993, SEC.25.
Nearby Sections
15
§ 16-18-1-1
Application of definitions§ 16-18-1-3
References to federal statutes or regulations relating to the National
Voter Registration Act§ 16-18-1-4
Certain ordinances and plans void§ 16-18-2-0.2
"340B covered entity"§ 16-18-2-0.3
"340B program"§ 16-18-2-0.5
"Abatement"§ 16-18-2-1
"Abortion"§ 16-18-2-1.5
Repealed§ 16-18-2-1.6
"Abortion inducing drug"§ 16-18-2-1.7
"Abortion complication"§ 16-18-2-1.8
"Additional forensic services"§ 16-18-2-10
"Agency"§ 16-18-2-100
"Donor insemination"